The reduction in alcohol intake in vats by isoproterenol is attenuated by indomethacin but not enalapril: Relationship to blood glucose levels

Psychopharmacology

Volumn 138, Issue 2, 1998, Pages 167-175

  Grupp, L A ^a,b   Lau, V ^b   Harding, S ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Ace inhibitor; Alcohol drinking; Angiotensin II; Blood glucose; Enalapril; Indomethacin; Isoproterenol

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; INDOMETACIN; ISOPRENALINE;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRINKING BEHAVIOR; DRUG EFFECT; GLUCOSE BLOOD LEVEL; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADRENERGIC BETA-AGONISTS; ALCOHOL DRINKING; ANALYSIS OF VARIANCE; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD GLUCOSE; DRINKING; ENALAPRIL; ETHANOL; HYPERGLYCEMIA; INDOMETHACIN; ISOPROTERENOL; MALE; RATS; RATS, WISTAR;

EID: 0031848308     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050659     Document Type: Article

References (52)

1. Alcoholics Anonymous (1987) Living sober. Alcoholics Anonymous World Services, New York, p 23
2. Amit Z, Levitan DE, Lindros KO (1976) Suppression of ethanol intake following administration of dopamine beta hydroxylase inhibitors. Arch Int Pharmacodyn Ther 223: 114-119
3. Amit Z, Brown ZW, Levitan DE Ogren S-O (1977) Noradrenergic mediation of the positive reinforcing properties of ethanol: I. Suppression of ethanol consumption in laboratory rats following dopamine beta hydroxylase inhibition. Arch Int Pharmacodyn Ther 223: 65-75
4. Balkau B, Eschwege E, Ducimetiere P, Richard JL, Warnet JM (1991) The high risk of death by alcohol related diseases in sujects diagnosed as diabetic and impaired glucose tolerance: the Paris prospective study after 15 years of follow up. J Clin Epidemiol 44: 465-464
5. Belknapp JK, Crabbe JC, Young ER (1993) Voluntary consumption of ethanol in 15 inbred mouse strains. Psychopharmacology 112: 503-510
6. Bialik RJ, Smythe JW, Roberts DCS (1988) Alpha 2 adrenergic receptors mediate the increase in blood glucose levels induced by epinephrine and brief foot shock stress. Prog Neuropsychopharmacol Biol Psychiatry 12: 397-314
7. Brands B, Naranjo CA, Tighe JW, Collis RS, Sellers EM (1992) Effecys of angiotensin converting enzyme inhibitors on free choice ethanol consumption by rats. In: Naranjo CA, Sellers EM (eds) Novel pharmacological interventions for alcoholism. Springer, New York, pp 353-355
8. Brown ZW, Amit Z (1977) The effects of selective catecholamine depletions by 6-hydroxydopamine on ethanol preference in rats. Neurosci Lett 5: 333-336
9. 1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino) tetralin in the conscious rat. J Pharmacol Exp Ther 243: 1159-1166
10. Connelly DM, Unwin JW, Taberner PV (1983) The role of the blood glucose level in determining voluntary ethanol consumption in the LACG and diabetogenic C57BI strains of mice. Biochem Pharmacol 32: 221-226
11. Crane M, Yung L, Beirne J, Gordis E (1987) The diabetic alcoholic: characteristics and treatment outcome. Drug Alcohol Depend 20: 39-46
12. Docherty JM, Harding S, Grupp LA (1993) Reduction of ethanol intake by aerosol inhalation of a beta adrenergic agonist: new route - new treatment approach? Alcohol Clin Exp Res 17: 1051-1054
13. Elmer GI, George FR (1991) The role of prostaglandin synthetase in the rate depressant effects and narcosis caused by ethanol. J Pharmacol Exp Ther 256: 1139-1146
14. George FR (1989) Role of arachidonic acid metabolites in mediating ethanol self-administration and intoxication. Ann NY Acad Sci 559: 382-391
15. George FR, Ritz MC, Collins AC (1979) Prostaglandin synthetase inhibitors antagonize ethanol-induced activation in selected lines of mice. Behav Genet 9: 453
16. George FR, Jackson SJ, Collins AC (1981) Prostaglandin synthetase inhibitors antagonize hypothermia induced by sedative hypnotics. Psychopharmacology 74: 241-244
17. George FR, Elmer GI, Collins AC (1982) Indomethacin significantly reduces mortality due to acute ethanol overexposure. Subst Alcohol Actions/Misuse 3: 267-274
18. Goas JA, Pelham RW, Lippa AS (1979) Endocrine factors contributing to the ethanol preferences of rodents. Pharmacol Biochem Behav 10: 557-560
19. Gosnell BA, Krahn DD (1992) The relationship between saccharin and alcohol intake in rats. Alcohol 9: 203-206
20. Grupp LA, (1991) Effects of angiotensin II and an angiotensin converting enzyme inhibitor on alcohol intake in P and NP rats. Pharmacol Biochem Behav 41: 105-108
21. Grupp, LA (1993) The renin-angiotensin-aldosterone system as a regulator of alcohol consumption: a review and some new insights. Alcohol and the Endocrine System, NIAAA Monograph #23
22. Grupp LA, Perlanski E (1979) Ethanol-induced changes in the spontaneous activity of single units in the hippocampus of the awakerat: a dose-response study. Neuropharmacology 18: 63-70
23. Grupp LA, Elias J, Perlanski E, Stewart RB (1985) Modification of ethanol-induced motor impairment by diet, diuretic, mineralocorticoid or prostaulandin synthetase inhibitor. Psychopharmacology 87: 20-24
24. Grupp, LA, Perlanski E, Stewart RB (1988) Attenuation of alcohol intake by serotonin uptake inhibitors: evidence for mediation through the renin-angiotensin system. Pharmacol Biochem Behav 30: 823-827
25. Grupp LA, Sneddon B, Solway E, Perlanski E, Stewart RB (1989) The beta adrenergic agonist isoproterenol suppresses voluntary alcohol intake in ruts. Pharmacol Biochem Behav 33: 493-495
26. Grupp LA, Hsu G, Ng N, Harding S (1997a) Glucose and the insulin-releasing drug tolbutamide attenuate the effects of morphine and angiotensin on alcohol consumption. Alcohol 14: 71-80
27. 2 adrenergic antagonist idazoxan correlates with blood glucose levels. Psychopharmacology 133: 172-178
28. Houpt KA, Epstein AN (1971) The complete dependence of beta adrenergic drinking on the renal dipsogen. Physiol Behav 7: 897-902
29. Hubbell CL, Chrisbacher GA, Bilsky EJ, Reid LD (1992) Manipulations of the renin-angiotensin system and intake of a sweetened alcoholic beverage among rats. Alcohol 9: 53-61
30. Kampov-Polevoy AB, Kasheffskaya OP, Sinclair JB (1990) Initial acceptance of ethanol: gustatory factors and patterns of alcohol drinking. Alcohol 7: 83-85
31. Kampov-Polevoy AB, Overstreet DH, Rezvani AH, Janowsky DS (1995) Saccharin-induced increase in daily fluid intake as a predictor of voluntary alcohol intake in alcohol-preferring rats. Physiol Behav 57: 791-795
32. Keilman PA (1983) Alcohol consumption and diabetes mellitus mortality in different countries. Am J Pub Health 73: 1316-1317
33. 3 receptor antagonist in the regulation of alcohol intake. Alcohol Alcohol 29 [Suppl 2]: 545-550
34. Lingham T, Perlanski E, Grupp LA (1990) Angiotensin converting enzyme inhibitors reduce alcohol consumption: some possible mechanisms and important conditions for its therapeutic use. Alcohol Clin Exp Res 14: 92-99
35. Linseman MA (1987) Alcohol consumption in free-feeding rats: procedural, genetic and pharmacokinetic factors. Psychopharmacology 92: 254
36. MacDonall JS, H. Marcucella H (1979) Increasing the rate of ethanol consumption in food-and water-satiated rats. Pharmacol Biochem Behav 10: 211
37. Machado LJC, Mihessen-Neto I, Marubayashi U, Reis AM, Coimbra CC (1995) Hyperglycemic effect of angiotensin II in freely moving rats. Peptides 16: 479-483
38. McLaughlin CL, Baile CA, Gingerich RL, Michel ME (1986) Influence of nalmefene on energy balance and glucose regulation in Zucker rats. Physiol Behav 37: 899-908
39. Mihessen-Neto I, Reis AM, Marubayashi U, Coimbra CC (1996) Effect of sympathoadrenal blockade on the hyperglycemic action of angiotensin II. Neuropeptides 30: 303-308
40. Myers RD (1994) New drugs for the treatment of experimental alcoholism. Alcohol 11: 439-451
41. Nabarro JD (1991) Diabetes in the United Kingdom: a personal series. Diabet Med 8: 59-68
42. Nascimento EA, Yamamoto NS, Bracht A, Ishii-Iwamoto EL (1995) Naproxen inhibits hepatic glycogenolysis induced by Ca(2+)-dependent agents. Gen Pharmacol 26: 211-218
43. Overstreet DH, Kampov-Polevoy AB, Rezvani, AH, Murrelle L, Halikas JA, Janowsky DS (1993) Saccharin predicts ethanol intake in genetically heterogeneous rats as well as different rat strains. Alcohol Clin Exp Res 17: 366-369
44. Papoz L, Eschwege E, Warnet JM, Richard JL, Claude JP (1982) Incidence of risk factors in diabetes in the Paris prospective study. In: Eschwege E (ed) Advances in diabetes epidemiology. Elsevier, Amsterdam, pp 113-122
45. Potter DE, Ellis S (1975) Isoproterenol and epinepherine-induced changes in blood glucose and tissue glycogen levels in normal and diabetic rats: the influence of alteration in endogenous insulin levels and state of nourishment. J Pharmacol Exp Ther 193: 576-584
46. Roane DS, Paul D (1991) Evidence of hyperglycemic hyperalgesia by quinpirole. Pharmacol Biochem Behav 41: 65-67
47. Robertson JM, Harding S, Grupp LA (1993) Captopril and hydrochlorothiazide (Capozide) combine to enhance the reduction in voluntary alcohol intake in rats. Alcohol Clin Exp Res 17: 951-957
48. Roy A, Virrkunen M, Linnoila M (1988) Monoamines, glucose metabolism, aggression towards self and others. Int J Neurosci 41: 261-264
49. Schiffrin EL, Genest J (1982) Mechanism of captopril-induced drinking. Am J Physiol 242: R136-R140
50. Sinclair JD, Kampov-Polevoy AB, Stewart R, Li TK (1992) Taste preference in rat lines selected for low and high alcohol consumption. Alcohol 9: 155-160
51. Spinosa G, Perlanski E, Leenen FHH, Stewart RB, Grupp LA (1988) Angiotensin converting enzyme inhibitors: animal experiments suggest a new pharmacological treatment for alcohol abuse in man. Alcohol Clin Exp Res 12: 65-70
52. Yung L, Gordis E, Holt J (1983) Dietary choices and likelihood of abstinence among alcoholic patients in an outpatient clinic. Drug Alcohol Depend 12: 355-362